GENETIC MANIPULATION OF EGR-R EXPRESSION AND RADIOSENSITIVITY OF CARCINOMA CELLS
癌细胞 EGR-R 表达和放射敏感性的基因操纵
基本信息
- 批准号:6336435
- 负责人:
- 金额:$ 10.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2001-07-31
- 项目状态:已结题
- 来源:
- 关键词:MCF7 cell apoptosis biological signal transduction breast neoplasms carcinoma cell line cell proliferation cyclin dependent kinase epidermal growth factor gene expression gene induction /repression gene therapy genetic regulation genetic transduction growth factor receptors ionizing radiation mitogen activated protein kinase neoplasm /cancer radiation therapy neoplastic growth radiation genetics radiation sensitivity receptor expression squamous cell carcinoma transfection transforming growth factors
项目摘要
DESCRIPTION: (Applicant's Description) Many human carcinoma cell lines are
regulate in their proliferation through autocrine growth regulation
involving growth factors, e.g. epidermal growth factor (EGF) or
transforming GF-alpha (TGF-alpha), and members of the EGF receptor (EGFR)
receptor tyrosine kinases (RTK), Ionizing radiation (IR) in the
therapeutic dose range activates EGFR and with repeated exposure induces
up-regulation of EGFR, identifying EGFR as early and late IR response
gene. A number of downstream components of EGFR-dependent signal
transduction pathways are activated by IR including phospholipase C,
stimulation of p42/44 MAPkinase, and transcriptional up-regulation of c-
Fos. The significance of this activation is indicated by the fact that
single or repeated IR exposures can induce a measurable proliferation
response in mammary (MCC) and squamous carcinoma cells (SCC), As IR-
induced proliferation responses to repeated IR exposures have been
implicated in counteracting the toxic effects of IR disruption of this
response should result in improve radiotherapeutic outcomes. Disruption of
the IR-induced proliferation through genetic modulation of EGFR expression
is the overall objective of the proposed experimentation and will
accomplished through the following specific aims: (1) Generation of
additional MCC and SCC cells expressing inducible mitogenesis-deficient
(MUT) or antisense (AS) EGFR and their characterization with respect to
growth and expression profile of EGF/TGF-alpha and other erbB RTK; (2)
Mechanistic studies on the effects of EGFR-MUT/-AS expression on IR-
induced proliferation and stress pathways and their manipulation through
Adenovirus (Ad)-mediated transient transfections in order to shift he
balance of proliferation and stress responses with one endpoint of
apoptosis; (3) Correlation of studies under Specific Aim 2 with overall
cellular responses of IR-induced proliferation, clonogenic survival, and
apoptotic cell death; (4) As a first step toward the intervention of the
IR-induced proliferation responses through transient transfections of
EGFR-MUT/-AS, proven under Specific Aim 1-3, using an AD infection system
including characterization of those with respect to signal transduction
and overall cellular responses.
描述:(申请人的描述)许多人类癌细胞系是
通过自分泌生长调节调节其扩散
涉及生长因素,例如表皮生长因子(EGF)或
转换GF-Alpha(TGF-Alpha)和EGF受体(EGFR)的成员
受体酪氨酸激酶(RTK),电离辐射(IR)
治疗剂量范围激活EGFR,并反复接触诱导
EGFR的上调,将EGFR识别为IR的早期和晚期响应
基因。 EGFR依赖性信号的许多下游组件
通过包括磷脂酶C,包括磷脂酶C的IR激活转导途径
刺激p42/44 mapkinase,以及c-的转录上调
fos。这种激活的重要性表明了以下事实
单一或重复的IR暴露会引起可测量的增殖
乳腺(MCC)和鳞状癌细胞(SCC)的反应,
诱导对重复IR暴露的增生反应已是
涉及抵消IR中断的毒性作用
反应应导致改善放射治疗结果。破坏
IR诱导的通过EGFR表达的遗传调节引起的增殖
是拟议实验的总体目标,将
通过以下特定目的完成:(1)生成
表达诱导有丝分裂缺陷的其他MCC和SCC细胞
(mut)或反义(AS)egfr及其表征
EGF/TGF-Alpha和其他ERBB RTK的生长和表达谱; (2)
关于EGFR-MUT/AS表达对IR-的影响的机理研究
诱导的增殖和压力途径及其通过
腺病毒(AD)介导的瞬态转染以移动
平衡增殖和压力反应与一个端点
凋亡; (3)在特定目标2下的研究与总体
IR诱导的增殖,克隆生存和
凋亡细胞死亡; (4)作为迈向干预的第一步
IR诱导的增殖反应通过瞬时转染
egfr-mut/-as,使用广告感染系统在特定的目标1-3下进行了证明
包括在信号转导方面的表征
和整体细胞反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUPERT K. SCHMIDT-ULLRICH其他文献
RUPERT K. SCHMIDT-ULLRICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUPERT K. SCHMIDT-ULLRICH', 18)}}的其他基金
GENETIC MANIPULATION OF EGR-R EXPRESSION AND RADIOSENSITIVITY OF CARCINOMA CELLS
癌细胞 EGR-R 表达和放射敏感性的基因操纵
- 批准号:
6475009 - 财政年份:2001
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MANIPULATION OF EGR-R EXPRESSION AND RADIOSENSITIVITY OF CARCINOMA CELLS
癌细胞 EGR-R 表达和放射敏感性的基因操纵
- 批准号:
6203408 - 财政年份:1999
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES
细胞辐射反应的基因调节
- 批准号:
2895793 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES
细胞辐射反应的基因调节
- 批准号:
6172854 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
Genetic Modulation of Cellular Radiation Responses
细胞辐射反应的基因调节
- 批准号:
6671180 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES
细胞辐射反应的基因调节
- 批准号:
6663032 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MANIPULATION OF EGR-R EXPRESSION AND RADIOSENSITIVITY OF CARCINOMA CELLS
癌细胞 EGR-R 表达和放射敏感性的基因操纵
- 批准号:
6103325 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES
细胞辐射反应的基因调节
- 批准号:
6376339 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES
细胞辐射反应的基因调节
- 批准号:
2450564 - 财政年份:1998
- 资助金额:
$ 10.06万 - 项目类别:
RADIATION, ERBB ACTIVATION AND CELLULAR GROWTH CONTROL
辐射、ERBB 激活和细胞生长控制
- 批准号:
6376120 - 财政年份:1995
- 资助金额:
$ 10.06万 - 项目类别:
相似国自然基金
活性氧参与肿瘤细胞凋亡调控的系统生物学研究及其靶向干预策略研究
- 批准号:81301893
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
过度载荷诱导椎间盘细胞凋亡的力学生物信号转导机制
- 批准号:81272038
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
镍钛合金植入体引起表面细胞凋亡的关键因素研究
- 批准号:81101155
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
细胞凋亡信号转导网络多尺度建模及其在新抗肿瘤药物靶标识别方面的应用研究
- 批准号:61172183
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
硒蛋白基因变异影响氧化应激信号转导网络的分子机制
- 批准号:81172610
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
靶向 Ninjurin 通路治疗携带野生型 p53 的肿瘤的机制和治疗潜力
- 批准号:
10501882 - 财政年份:2022
- 资助金额:
$ 10.06万 - 项目类别:
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
靶向 Ninjurin 通路治疗携带野生型 p53 的肿瘤的机制和治疗潜力
- 批准号:
10650436 - 财政年份:2022
- 资助金额:
$ 10.06万 - 项目类别:
Acoustically-driven optical-interferometric microscope for cell characterization
用于细胞表征的声学驱动光学干涉显微镜
- 批准号:
10322456 - 财政年份:2021
- 资助金额:
$ 10.06万 - 项目类别:
Using Quantitative Proteomics to Elucidate the Signaling Consequences of Microtubule Disruption
使用定量蛋白质组学阐明微管破坏的信号传导后果
- 批准号:
9051090 - 财政年份:2016
- 资助金额:
$ 10.06万 - 项目类别:
Using Quantitative Proteomics to Elucidate the Signaling Consequences of Microtubule Disruption
使用定量蛋白质组学阐明微管破坏的信号传导后果
- 批准号:
9237119 - 财政年份:2016
- 资助金额:
$ 10.06万 - 项目类别: